Bokus

Morton Swartz – författare

Visar alla böcker från författaren Morton Swartz. Handla med fri frakt och snabb leverans.

3 produkter

  1. Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Institute of Medicine, Frederick J. Manning, Morton Swartz - Review of the Fialuridine (FIAU) Clinical Trials, E-bok. Tillgänglighet: Lägg i varukorg

    Review of the Fialuridine (FIAU) Clinical Trials

    Av Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Institute of Medicine m. fl.

    E-bok, 1995

    731 kr

    Lägg i varukorg

    In June 1993 a clinical trial of fialuridine (FIAU), a promising new medication for hepatitis B, was abruptly terminated when one of the 15 out-patients participating in the National Institutes of Health (NIH) study was suddenly hospitalized with liver failure. Although all the remaining patients …

  2. Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Institute of Medicine, Frederick J. Manning, Morton Swartz - Review of the Fialuridine (FIAU) Clinical Trials, E-bok. Tillgänglighet: Lägg i varukorg

    Review of the Fialuridine (FIAU) Clinical Trials

    Av Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Institute of Medicine m. fl.

    E-bok, 1995

    473 kr

    Lägg i varukorg

    In June 1993 a clinical trial of fialuridine (FIAU), a promising new medication for hepatitis B, was abruptly terminated when one of the 15 out-patients participating in the National Institutes of Health (NIH) study was suddenly hospitalized with liver failure. Although all the remaining patients …

  3. Institute of Medicine, Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Morton Swartz, Frederick J. Manning - Review of the Fialuridine (FIAU) Clinical Trials, Häftad. Tillgänglighet: Tillfälligt slut

    Review of the Fialuridine (FIAU) Clinical Trials

    Av Institute of Medicine, Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials m. fl.

    Häftad, 1995

    1442 kr

    Tillfälligt slut

    In June 1993 a clinical trial of fialuridine (FIAU), a promising new medication for hepatitis B, was abruptly terminated when one of the 15 out-patients participating in the National Institutes of Health (NIH) study was suddenly hospitalized with liver failure. Although all the remaining patients …